Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved
MMW Fortschritte der Medizin Suppl. 2: 88
2002
ISSN/ISBN: 1438-3276 PMID: 12070869 Document Number: 551448
Document emailed within 1 workday
Related Documents
Levin, O.S.; Nesterova, O.S.; Otcheskaia, O.V.; Zhuravleva, E.I.; Artemova, I.I.; Khozova, A.A.; Ismailov, A.M.; Lisenker, L.N.; Vdovichenko, T.V.; Rotor, L.D.; Ganzula, P.A.; Ivanov, A.K.; Boĭko, A.N. 2009: Influence of dopamine agonist pramipexole (mirapex) on tremor, cognitive and affective impairment in patients with Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(8): 36-41Molho, E.S.; Factor, S.A.; Weiner, W.J.; Sanchez-Ramos, J.R.; Singer, C.; Shulman, L.; Brown, D.; Sheldon, C. 1995: The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease Journal of Neural Transmission. Supplementum 45: 225-230
Jenner, P. 2005: A novel dopamine agonist for the transdermal treatment of Parkinson's disease Neurology 65(2 Suppl 1): S3-S5
Sweet, R.D.; Wasterlain, C.; McDowell, F.H. 1974: Piribedil--an oral dopamine agonist for treatment of Parkinson's disease Transactions of the American Neurological Association 99: 258-260
Bode, M. 2009: Dopamine agonist therapy in early Parkinson's disease. a survey of a Cochrane review Ugeskrift for Laeger 171(41): 2996-2999
Biernat, H.; Ellias, S.A.; Wermuth, L.; Cleary, D.; de Oliveira Santos, E.C.; Jørgensen, P.J.; Feldman, R.G.; Grandjean, P. 1999: Tremor frequency patterns in mercury vapor exposure, compared with early Parkinson's disease and essential tremor Neurotoxicology 20(6): 945-952
Inoue, M.; Mima, T.; Kojima, Y.; Satoi, H.; Makino, F.; Kanda, M.; Shibasaki, H. 2007: A case presenting with both features of essential tremor and Parkinson tremor Rinsho Shinkeigaku 47(7): 413-418
Growdon, J.H.; Young, R.R.; Shahani, B.T. 1975: The differential diagnosis of tremor in Parkinson's disease Transactions of the American Neurological Association 100: 197-199
Miranda-Lloret, P.; Pascual-Martín, B.; Arrese-Regañón, I.; Pérez-Núñez, A.; Alday-Anzola, R.; Díez-Lobato, R. 2004: Neurochemical treatment of Parkinson's disease and essential tremor Revista de Neurologia 39(10): 978-983
Malmberg; Mikaels; Mohell, N. 1998: Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding Journal of Pharmacology and Experimental Therapeutics 285(1): 119-126
Rezvanian, S.; Lockhart, T.; Frames, C.; Soangra, R. 2017: Toward an Objective Method to Classify Tremor Dominant and Postural Instability and Gait Difficulty Subtypes of Parkinson's Disease: a Pilot Study Biomedical Sciences Instrumentation 53: 138-142
Gekht, A.B. 2002: Use of dopamine agonists in the treatment of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(9): 54-58
Kohli, J.D.; Goldberg, L.I.; Volkman, P.H.; Cannon, J.G. 1978: N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist Journal of Pharmacology and Experimental Therapeutics 207(1): 16-22
Kish, S.; Rajput, A.; Gilbert, J.; Rozdilsky, B.; Chang, L.J.; Shannak, K.; Hornykiewicz, O. 1987: GABA-dopamine relationship in Parkinson's disease striatum Advances in Neurology 45: 75-77
Stoessl, A.J.; de la Fuente-Fernández, R.úl. 2003: Dopamine receptors in Parkinson's disease: imaging studies Advances in Neurology 91: 65-71
Olanow, C.Warren. 2002: The role of dopamine agonists in the treatment of early Parkinson's disease Neurology 58(4 Suppl 1): S33-S41
Gerfen, C.R. 2000: Dopamine-mediated gene regulation in models of Parkinson's disease Annals of Neurology 47(4 Suppl 1): S42
Yamamoto, M. 2004: Depression in Parkinson's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(9): 1661-1666
Mignot, B.; Ollat, H. 1982: Parkinson disease and depression La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(14): 859-861
Hornykiewicz, O. 2001: Dopamine and Parkinson's disease. a personal view of the past, the present, and the future Advances in Neurology 86: 1-11